Cargando…

The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes

Osteoarthritis (OA) is a cartilage degenerative disease commonly observed in the elderly population and is pathologically characterized by the degradation of the cartilage extracellular matrix (ECM). Matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yunlong, Liu, Junyi, Ma, Yan, Zhang, Yongyong, Chen, Qiong, Yang, Xin, Shang, Yanchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805962/ https://www.ncbi.nlm.nih.gov/pubmed/35012432 http://dx.doi.org/10.1080/21655979.2021.1997090

Ejemplares similares

Interleukin‐29 profiles in COVID‐19 patients: Survival is associated with IL‐29 levels
por: Fallah Vastani, Zahra, et al.
Publicado: (2022)

Interleukin-29 Enhances Synovial Inflammation and Cartilage Degradation in Osteoarthritis
por: Xu, Lingxiao, et al.
Publicado: (2016)

MicroRNA-29b Contributes to Collagens Imbalance in Human Osteoarthritic and Dedifferentiated Articular Chondrocytes
por: Moulin, David, et al.
Publicado: (2017)

MiR-29a and MiR-140 Protect Chondrocytes against the Anti-Proliferation and Cell Matrix Signaling Changes by IL-1β
por: Li, Xianghui, et al.
Publicado: (2016)

The role of IL-29 in immunity and cancer
por: Kelm, Noah E., et al.
Publicado: (2016)

Bax Targeted by miR-29a Regulates Chondrocyte Apoptosis in Osteoarthritis
por: Miao, Guiqiang, et al.
Publicado: (2019)

Severe spruelike enteropathy and collagenous colitis caused by olmesartan
por: Kaneko, Shiho, et al.
Publicado: (2021)

Myrrh protects against IL-13-induced epithelial barrier breakdown in HT-29/B6 cells
por: Hader, Helena, et al.
Publicado: (2023)

Memorandum: Experiments in beam d29/29a
por: CERN. Geneva, et al.
Publicado: (1968)

Silencing of Wnt5a prevents interleukin-1β-induced collagen type II degradation in rat chondrocytes
por: Shi, Shiping, et al.
Publicado: (2016)

Insights into IL‐29: Emerging role in inflammatory autoimmune diseases
por: Wang, Jia‐Min, et al.
Publicado: (2019)

Primavera 29 /
por: Ganz, Irene G. de
Publicado: (2003)

miR-29b inhibits TGF-β1-induced cell proliferation in articular chondrocytes
por: Horita, Masahiro, et al.
Publicado: (2022)

Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis
por: Wang, Fang, et al.
Publicado: (2012)

Effect of Interleukin-29 on Interferon-α Secretion by Peripheral Blood Mononuclear Cells
por: Cho, Chi Hyun, et al.
Publicado: (2015)

TRIM29 negatively controls antiviral immune response through targeting STING for degradation
por: Li, Qijie, et al.
Publicado: (2018)

2,9‐Diazadibenzoperylene and 2,9‐Dimethyldibenzoperylene‐1,3,8,10‐tetratriflates: Key to Functionalized 2,9‐Diazaperopyrenes
por: Baal, Eduard, et al.
Publicado: (2021)

Epigallocatechin-3-O-gallate promotes extracellular matrix and inhibits inflammation in IL-1β stimulated chondrocytes by the PTEN/miRNA-29b pathway
por: Yang, Dong, et al.
Publicado: (2022)

EXM 84-29
Publicado: (1984)

Symphonies No. 29 &33/
por: Gardiner, John Eliot

29-December 2008
Publicado: (2008)

FEC91#29
Publicado: (1991)

EXM-83-29
Publicado: (1983)

CCM Extended no. 29
Publicado: (1978)

EXM-86-29
por: Daems, G
Publicado: (1987)

EXM 89-29
por: Daems, G
Publicado: (1989)

Index to volume 29
Publicado: (2003)

Friend or foe: Endoplasmic reticulum protein 29 (ERp29) in epithelial cancer
por: Chen, Shaohua, et al.
Publicado: (2015)

Identification of a dominant murine T-cell epitope in recombinant protein P29 from Echinococcus granulosus : Protective rEg.P29 epitope against E. granulosus
por: Lv, Yongxue, et al.
Publicado: (2022)

Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus
por: Diegelmann, Julia, et al.
Publicado: (2010)

Production of interleukin (IL)-1 receptor antagonist by human articular chondrocytes
por: Palmer, G, et al.
Publicado: (2002)

Enhanced serum interferon-lambda 1 interleukin-29 levels in patients with psoriasis vulgaris()()
por: Fu, Li-xin, et al.
Publicado: (2021)

Acute Gastrointestinal Bleeding in Olmesartan-Associated Collagenous Gastroduodenitis: A Potential Endoscopic Complication
por: Hudacko, Rachel, et al.
Publicado: (2018)

Evaluation of IL-29 in Euthyroid Patients with Graves' Orbitopathy: A Preliminary Study
por: Falkowski, Bogusz, et al.
Publicado: (2020)

Chitosan-Coated Collagen Membranes Promote Chondrocyte Adhesion, Growth, and Interleukin-6 Secretion
por: Mighri, Nabila, et al.
Publicado: (2015)

$^{29}$Si(d,$^{3}$He)$^{28}$Al reaction at 29 MeV
por: Vernotte, J, et al.
Publicado: (1994)

Validation of Persian Multiple Sclerosis quality of life-29 (P-MSQOL-29) questionnaire
por: Hassanzadeh, Morteza, et al.
Publicado: (2023)

Regulatory Role of the MicroRNA-29b-IL-6 Signaling in the Formation of Vascular Mimicry
por: Fang, Jian-Hong, et al.
Publicado: (2017)

Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015)

MiR‐29b‐3p promotes chondrocyte apoptosis and facilitates the occurrence and development of osteoarthritis by targeting PGRN
por: Chen, Lingqiang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b5cicj8ijm3ru2kv7bal3upjvn